10% Owner HRT Financial LP Makes Substantial Net Purchase of CMND Shares
CMND sits 55% above its 52-week low of $2.1 on light trading volume (0.1× avg).
Summary
HRT Financial LP, a 10% owner of Clearmind Medicine Inc., reported a net purchase of over $300,000 in common stock, significantly increasing its stake in the micro-cap company.
Key Events · Ownership and Investor Activity · CMND
-
Substantial Open Market Purchase
HRT Financial LP acquired 2,159,052 shares of common stock for $330,335 at an average price of $0.153 per share on June 10, 2026.
-
Minor Open Market Sale
The same insider disposed of 225,191 shares for $27,698 at an average price of $0.123 per share on June 11, 2026.
-
Significant Net Increase in Holdings
The net effect of these transactions is an increase of 1,933,861 shares, representing a net investment of $302,636 by the 10% owner.
-
Post-Split Transactions
These transactions occurred after the 1-for-10 reverse stock split on May 21, 2026, meaning the reported share counts and prices are post-split values.
Analysis · CMND · Life Sciences
This Form 4 filing indicates a significant vote of confidence from HRT Financial LP, a 10% owner. The net purchase of over $300,000 represents a substantial portion of Clearmind Medicine's current market capitalization, especially for a micro-cap company. This large insider purchase is a notable positive signal amidst recent dilutive capital-raising activities and a reverse stock split, suggesting a bullish outlook from this key investor.
How filings like this one have moved
In the 30 days to Sep 13, 2026, 35.6% of the 1216 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CMND was trading at $3.25 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.4M. The 52-week trading range was $2.10 to $524.00. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.